ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Obesity"

  • 2021 American Transplant Congress

    Body Mass Index >35 Does Not Impact Kidney Transplant Outcomes or Health Related Quality of Life Despite BMI Class or Recipient Race

    D. A. Walczak1, E. Collins2, E. Benedetti1

    1Organ Transplant, University of Il Hospital and Health Sciences System, Chicago, IL, 2College of Nursing, Dept of Bio-behavioral Health Science, University of Illinois at Chicago, Chicago, IL

    *Purpose: Kidney transplant [KTx] in recipients with BMI > 35 remains controversial and has not often been studied in recipients with BMI >40. There is…
  • 2021 American Transplant Congress

    Ganciclovir Therapeutic Drug Monitoring in Obese Adults Patients – Opportunity for Clinical Utility

    Y. Tran1, S. Bernard1, R. W. Stevens1, L. Myhre1, R. Razonable2

    1Department of Pharmacy, Mayo Clinic, Rochester, MN, 2Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN

    *Purpose: Ganciclovir (GCV) is the drug of choice for the treatment of cytomegalovirus (CMV) infection; optimal dosing of GCV in the obese patient population is…
  • 2021 American Transplant Congress

    Outcomes of Simultaneous Kidney-Pancreas Transplantation in Patients with Type-I and Type-II Diabetes Mellitus

    H. Shokouh-Amiri1, M. S. Naseer1, A. Palermini1, D. Aultman1, R. McMillan1, S. Tandukar2, N. Singh2, G. Zibari1

    1Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, 2Transplant Nephrology, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA

    *Purpose: UNOS approved simultaneous kidney-pancreas transplantation (SKPT) for type-II diabetes mellitus (DM) in Oct 2014. There is limited data comparing outcomes of SKPT in type-I…
  • 2021 American Transplant Congress

    Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery

    C. LaVerne, V. Thompson, G. Aguiluz, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti

    Surgery, University of Illinois Hospital & Health Sciences System, Chicago, IL

    *Purpose: Obesity is an epidemic in the US and increasingly prevalent in kidney transplant candidates. Surgical weight-loss interventions are effective and reduce transplant-related complications. They…
  • 2021 American Transplant Congress

    Predictors of Postoperative Atrial Fibrillation in an Urban, Obese Adult Renal Transplant Population

    A. Lichvar, Z. Ress, M. Tabriz, H. Jenkins, T. Walsh, I. Tzvetanov, E. Benedetti, M. Campara

    University of Illinois at Chicago, Chicago, IL

    *Purpose: Postoperative atrial fibrillation (POAF) is a common surgical complication. Renal transplant (RT) recipients possess risk factors that may lead to a higher incidence of…
  • 2021 American Transplant Congress

    Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients

    C. Patel, S. Lee, D. M. Salerno, N. W. Lange, J. Hedvat

    Pharmacy, NewYork-Presbyterian Hospital, New York, NY

    *Purpose: Envarsus XR® (extended-release [XR] tacrolimus) is the standard of care tacrolimus formulation at our center for de novo maintenance immunosuppression in adult kidney transplant…
  • 2021 American Transplant Congress

    Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion

    D. Pierce, J. Benken, P. West-Thielke, I. Tzvetanov, E. Benedetti, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: There is limited data regarding belatacept conversion in obese patients as an alternative to calcineurin inhibitor (CNI) immunosuppression. Pharmacokinetic (PK) data suggests increasing clearance…
  • 2021 American Transplant Congress

    Application of Incisional Wound Vac to Decrease Wound Complications and Surgical Site Infections: A Single Center Pilot Project

    E. K. Venniro, M. Dokus, J. Taylor, R. Kashyap

    University of Rochester Medical Center, Rochester, NY

    *Purpose: Wound complications and surgical site infections (SSIs) are common but morbid complications of transplant in immunosuppressed patients. Kidney transplant patients who are obese, highly…
  • 2021 American Transplant Congress

    Nutrition, Body Habitus, and Food Insecurity, in Pediatric Kidney Transplant Recipients

    A. Wilkerson1, J. Figueroa1, C. Kang1, R. Garro2, M. Kamel1, R. P. George2

    1Emory University, Atlanta, GA, 2Emory University and Children's Healthcare of Atlanta, Atlanta, GA

    *Purpose: Appropriate nutrition and physical activity are critical for optimal post-transplant recovery and long term outcomes, especially in pediatric populations. Both malnutrition and obesity are…
  • 2021 American Transplant Congress

    Obesity is a Risk Factor for Progression to Kidney Transplant Waitlisting After Liver Transplantation

    B. Shelton1, B. Orandi1, K. Olthoff2, E. Pomfret3, K. Forde2, D. Sawinski2, M. Gray1, N. Ascher4, J. Locke1

    1University of Alabama at Birmingham, Birmingham, AL, 2University of Pennsylvania, Philadelphia, PA, 3University of Colorado School of Medicine, Aurora, CO, 4University of California San Francisco, San Francisco, CA

    *Purpose: Non-alcoholic steatohepatitis (NASH) has emerged as a leading cause of cirrhosis, and obesity-associated comorbid conditions, including renal disease have become more prevalent. Obesity predisposes…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences